Bill Gates raises concerns over U.S. aid cuts' impact on HIV programs in Africa and calls for a reversal of the decision.

This new FDA-approved shot is designed to break down the barriers that have kept too many people from accessing PrEP.

Merck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its ...

Government should increase their allocation to the health sector to at least 15 percent of the total National Budget ...

A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...

The report emphasises the urgent need for countries to implement radical changes in their HIV programming and funding ...

Gilada, the only Indian serving on the International AIDS Society (IAS) Governing Council, assured the country has the ...

Amarna Therapeutics and NorthX Biologics finalized an agreement to advance Nimvec AM510 gene therapy toward clinical trials for Type 1 Diabetes. Now in its fourth year, the MM+M Media Summit brings ...

About 17,000 people are set to benefit from free access to the long-acting HIV prevention injection, lenacapavir, which only needs to be administered twice a year. This follows a new ...

A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.

Six months of prevention -- that's how long Lenacapavir, the new drug for HIV prevention lasts.The Food and Drug Administration approved it last month, and desp ...

If approved, doravirine/islatravir would be the first two-drug HIV treatment regimen without an integrase inhibitor, ...